BioSpace News Archive

Pharm Country

Chubb Introduces Gap Supplement Insurance to Help Offset Rising Out-of-Pocket Medical Expenses for Consumers

Chubb has introduced its new Gap Supplement Medical plan – an enhanced supplemental healthcare insurance product designed to reimburse consumers for qualifying out-of-pocket expenses not reimbursed by their medical insurance plans

December 5, 2018
·
3 min read
Business

Dendreon Signs Long-Term Lease Agreement for South Lake Union Office and Laboratory Space

Dendreon Pharmaceuticals LLC, a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy, today announced it has signed a long-term lease agreement for its current South Lake Union location

December 5, 2018
·
1 min read
Policy

Covidien LP Agrees to Settle Medicare Fraud Lawsuit for $13 Million

Berger Montague is pleased to announce that Covidien LP (“Defendant”) agreed to pay $13 million to resolve a False Claims Act lawsuit filed by Shareholder Shauna Itri on behalf of her client in November 2015.

December 5, 2018
·
2 min read
CEA Will Demonstrate Five Innovations for the E-mobility, Green Energy, Connected Health, Digital Camera and Agri-food Markets at CES 2019

The Alternative Energies and Atomic Energy Commision, Europe’s most innovative research center today announces it will host booth #50653 at CEA Tech Village, during CES 2019

December 5, 2018
·
2 min read
Pharm Country

Tris Pharma Issues Voluntary Nationwide Recall of Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, Due to Potential Higher Concentrations of Ibuprofen

Monmouth Junction, NJ, Tris Pharma, Inc. has voluntarily recalled three (3) lots of Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, to the retail level.

December 5, 2018
·
3 min read
Drug Development

OncoNano Announces Completion of Phase 1a Study and Expands into Phase 1b for Intraoperative Imaging Agent to Detect Tumors and Metastatic Lymph Nodes That Often Go Undetected During Surgery

OncoNano Medicine, Inc. today announced the completion of its Phase 1a clinical trial and expansion into Phase 1b to evaluate ONM-100, the intravenously administered imaging agent to detect tumors and metastatic lymph nodes in solid cancers during surgery.

December 5, 2018
·
2 min read
QxMD Software’s Content Engagement Platform Tops 200 Million Annual Views by Healthcare Professional (HCP) Members

QxMD Software Inc., a digital learning technology company that helps healthcare professionals (HCPs) to advance clinical practice with evidence-based research and decision support tools, today announced that the company had achieved a new membership milestone by exceeding the 200 million mark for annual aggregate views across the company’s HCP content engagement platform QxMD Pathways.

December 5, 2018
·
2 min read
Drug Development

Apexian Pharmaceuticals Presents Data on Their Lead Drug for Anti-Chemotherapy-Induced Peripheral Neuropathy (CIPN), APX3330, at ASCO Palliative Care and Symptom Management Meeting

Chemotherapy causes chemotherapy-induced peripheral neuropathy (CIPN) in a significant number of patients, yet the pharmaceutical landscape is completely devoid of treatments to prevent CIPN.

December 5, 2018
·
2 min read
Pharm Country

Friend or Foe? Brain Area That Controls Social Memory Also Triggers Aggression, Mouse Study Reveals

Columbia research reveals importance of memory in driving key social behavior; offers insight into psychiatric disorders such as schizophrenia

December 5, 2018
·
5 min read
Biotech Beach

Lakeside Community Healthcare Takes On Diabetes with Interactive Program

The Diabetes Empowerment Education Program (DEEP™) shows people living with diabetes a path toward a healthier and happier life.

December 5, 2018
·
1 min read